MDS Tech Inc. (086960) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MDS Tech Inc. (086960:KRX), powered by AI.
- Current Price
- ₩2,500
- P/E Ratio
- 12.8
- Market Cap
- 105.3B
- Sector
- Common Stock
What is the MDS Tech Inc. stock price forecast?
MDS Tech Inc. is currently trading at ₩2,500. View real-time AI analysis on Alpha Lenz.
What is MDS Tech Inc. insider trading activity?
View the latest insider trading data for MDS Tech Inc. on Alpha Lenz.
What is MDS Tech Inc.'s P/E ratio?
MDS Tech Inc.'s P/E ratio is 12.8.
MDS Tech Inc.
KRX · 086960“MDS Tech Inc. trades at a P/E of 12.8 (undervalued) with modest ROE of 6.1%.”
Ask for details →Company Overview
MDS Tech Inc. is a technology solutions company that specializes in IT and telecommunications services. Its primary function is to deliver comprehensive technology solutions, including software development, system integration, and managed services, to businesses across various sectors. MDS Tech Inc. leverages advanced technologies to offer innovative solutions that help organizations enhance operational efficiency and adapt to the digital landscape. The company plays a significant role in the IT services industry, impacting sectors such as finance, healthcare, and manufacturing by streamlining their technology infrastructures. MDS Tech Inc.'s market significance is underscored by its ability to meet the evolving technological demands of businesses, thereby supporting digital transformation initiatives globally, and positioning itself as a key player within the technology service providers landscape.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“MDS Tech Inc. trades at a P/E of 12.8 (undervalued) with modest ROE of 6.1%.”
Ask for details →Frequently Asked Questions
MDS Tech Inc. (ticker: 086960) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $105.3B.
The current price is ₩2,500 with a P/E ratio of 12.8x and P/B of 0.74x.
ROE is 6.12% and operating margin is 3.10%. Annual revenue is $187.7B.